A NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING ALZEIMER'S DEMENTIA

摘要

The present invention relates to a pharmaceutical composition and, more specifically, to a novel pharmaceutical composition for treating Alzheimers disease, comprising osmotin as an active ingredient. In addition, a health functional food for alleviating recognition and dysmnesia comprising Alzheimers disease and enhancing memory can be produced.